Delivery Order SPE2DB20D1110-SPE2DB25FK31P
- Not listed
- The Defense Logistics Agency awarded a $60,405.91 delivery order to AmerisourceBergen Drug Corp for TREMFYA 100 mg/ml syringes on August 7, 2025, with completion scheduled for August 8, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. TREMFYA (guselkumab) is a biologic immunosuppressant used to treat plaque psoriasis and other inflammatory...
- The Defense Logistics Agency awarded a delivery order valued at $9,132.68 to AmerisourceBergen Drug Corp for TREMFYA 100 mg/ml syringes on August 11, 2025, with an ultimate completion date of August 12, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. TREMFYA is a prescription biologic medication used to treat moderate to severe plaque psoriasis and...
- The Defense Logistics Agency awarded a $59,710.11 delivery order to AmerisourceBergen Drug Corp for TREMFYA 100 mg/ml syringes, with performance to be completed by July 31, 2025. This is a firm fixed price, non-competitive delivery order executed on July 30, 2025, with performance occurring at AmerisourceBergen's Conshohocken, Pennsylvania facility. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX),...
- The Defense Logistics Agency awarded a $29,944.86 delivery order to AmerisourceBergen Drug Corp for TREMFYA 100 mg/mL pharmaceutical product on August 7, 2025, with completion scheduled for August 8, 2025. This competitively awarded, firm fixed-price contract involves no set-aside designation and specifies performance at the contractor's Conshohocken, Pennsylvania facility. TREMFYA is a biologic medication used primarily for treating moderate-to-severe plaque psoriasis and is being procured to...
- The Defense Logistics Agency awarded a delivery order valued at approximately $24,948 to AmerisourceBergen Drug Corp for TREMFYA 100 mg/mL syringes. This firm fixed price contract was competitively awarded without set-aside provisions and is set to be completed by August 12, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. TREMFYA is a prescription biologic medication used in the treatment of psoriasis and psoriatic arthritis,...
- The Defense Logistics Agency awarded a $21,765.75 firm fixed-price delivery order to AmerisourceBergen Drug Corp for TREMFYA 200 mg/2 ml pen injections on August 12, 2025, with an ultimate completion date of September 3, 2025. This competitive award carries no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. TREMFYA is a biologic medication used to treat autoimmune conditions including psoriasis and psoriatic arthritis,...
- The Defense Logistics Agency awarded a delivery order valued at $14,691.41 to AmerisourceBergen Drug Corp for TREMFYA 100 MG/ML, a prescription pharmaceutical product. The contract, issued on July 31, 2025, with an ultimate completion date of August 1, 2025, utilizes firm fixed pricing and carries no set-aside designation, indicating it was competitively awarded. Performance will occur at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency awarded a $21,765.75 delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of TREMFYA 200 mg/2 mL pen injections. This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of August 28, 2025. The pharmaceutical product will be delivered to the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued under...
- The Defense Logistics Agency awarded a $42,749.96 firm fixed-price delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of TREMFYA 100 mg/ml injectable medication. The order, which represents a child contract under a larger indefinite delivery vehicle, was competitively awarded without set-aside provisions and carries an ultimate completion date of August 13, 2025. Performance will be executed at the contractor's corporate office location in Conshohocken,...
- The Defense Logistics Agency's Medical Supply Chain awarded a $28,919.43 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Tremfya 100 mg/ml syringes. This non-set-aside contract was competitively awarded on July 23, 2025, with an ultimate completion date of July 24, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. Tremfya is a biologic immunosuppressant medication used in the treatment of psoriasis and other autoimmune...
- SPE2DB20D1110Indefinite Delivery Contract
- SPE2DB20D1110-SPE2DB25FK31PDelivery Order
The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $22,624.36 for TREMFYA 100 mg/mL syringes on August 4, 2025, with an ultimate completion date of August 5, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. TREMFYA (guselkumab) is a monoclonal antibody used to treat moderate to severe plaque psoriasis and other inflammatory conditions, representing part of the Defense Logistics Agency's ongoing pharmaceutical procurement operations. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. This prime contract vehicle enables AmerisourceBergen to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. As a major pharmaceutical distributor and critical federal healthcare vendor, AmerisourceBergen regularly fulfills federal medical procurement needs across multiple therapeutic domains for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems through both delivery orders and standing supply arrangements.